Uptake rate of carrier screening among consanguineous couples

Julianne Ricca,Justin S. Brandt,Natalie Jacob,Elena Ashkinadze
DOI: https://doi.org/10.1002/pd.6556
2024-03-19
Prenatal Diagnosis
Abstract:Objective To quantify the uptake rates of Carrier Screening (CS) in consanguineous couples and compare this rate to that of non‐consanguineous couples. Methods We performed a matched case control study of 82 consanguineous couples seen at Rutgers‐Robert Wood Johnson Medical school who were offered carrier screening between January 1, 2012 and October 10, 2022. We then matched each consanguineous female patient to a non‐consanguineous female control patient who was also offered CS at the time of their genetic counseling appointment. A 2 × 2 contingency table analysis was used to compare rates of acceptance and declination between the consanguineous and non‐consanguineous groups. Results The overall acceptance rate among consanguineous couples was 82.9%, whereas the overall acceptance rate among non‐consanguineous couples was 56.1%. After statistical analysis, consanguineous couples were significantly more likely to accept CS as compared to non‐consanguineous couples (OR = 3.801, 95% CI; p
genetics & heredity,obstetrics & gynecology
What problem does this paper attempt to address?